SIADH induced by pneumonia in a patient with Shy-Drager syndrome by Shota Ishibashi et al.
to find one previously reported case of such an impair-
ment9）. We report an interesting case of Shy-Drager 
syndrome in which SIADH developed with pneumonia.
CASE REPORT
A 71-year-old Japanese man had presented with or-
thostatic hypotension since he was 67 years old. His 
symptoms included a mask-like face, urinary retention, 
constipation, and rigidity at the age of 70 . He had a 
positive Myerson’s sign. He could not walk without us-
ing handrails because of postural instability. He under-
went some medical study at another hospital. The tilt 
test was positive. Urodynamics revealed a neurogenic 
bladder pattern. Single photon emission computed to-
mography revealed no evidence of decreased blood 
flow in the cerebellum or brain stem. Therefore, he 
was diagnosed as having Shy-Drager syndrome and 
treated with levodopa/carbidopa. He spoke softly in a 
monotone, presented with bulbar palsy, and was con-
fined to a wheelchair at the age of 70.
In June 2009, at the age of 71, he was admitted to 
our hospital because of pneumonia. On admission, he 
was alert, could not stand up. His blood pressure was 
150/74 mmHg；heart rate was 89 beats per minute 
INTRODUCTION
Orthostatic hypotension in patients with Shy-Drager 
syndrome （SDS） is partly caused by the impaired 
baroreceptor-mediated release of vasopressin （i.e., an-
tidiuretic hormone ［ADH］） when the patient is in an 
upright position1～4）. On the other hand, there is specu-
lation that the syndrome of inappropriate secretion of 
antidiuretic hormone （SIADH）, induced by pneumonia 
or intrathoracic disease, is caused by inflammation that 
has extended to the baroreceptors, by changes in pul-
monary blood flow, or by an abnormal respiratory pat-
tern5, 6）. However, the exact pathophysiology of SIADH 
induced by pneumonia or intrathoracic disease remains 
unknown7）. ADH release is inhibited by the afferent 
pathway of baroreceptors of the carotid sinus and the 
left atrium/ventricle；this pathway extends to the hy-
pothalamus by way of the vagus and nucleus tractus 
solitarius8）（Fig. 1）. An impairment in these inhibitory 
tracts may cause SIADH；however, we were only able 
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SUMMARY
Patients with Shy-Drager syndrome have impaired baroreceptor-mediated vasopressin release when in 
an upright position. We report a case of Shy-Drager syndrome in which the syndrome of inappropriate se-
cretion of antidiuretic hormone （SIADH） developed with pneumonia. It has been speculated that pneumo-
nia-induced SIADH is caused by baroreceptor-mediated vasopressin release. Our case presents the possibil-
ity that pneumonia-induced SIADH is caused by non-baroreceptor-mediated ADH release.
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（basal plasma cortisol concentration, 15 . 6 mg/dL）；
non-thyroid illness （FT4 , 1 .03 ng/dL；FT3, 1 .83 pg/
ml；TSH, 1 .53 mU/mL）；or dehydration （hematocrit, 
3 8 . 0；blood urea nitrogen, 1 7 mg/dL；creatinine, 
0.6 mg/dL） （Table 1）. He therefore apparently devel-
oped SIADH as a result of pneumonia.
He improved through the administration of oxygen, 
antibiotics, and fluid replacement. Serum sodium con-
centration, serum osmolality, serum uric acid concen-
tration, PRA, urine osmolality and plasma ADH con-
centration improved gradually （Table 2）. Because of 
dysphagia and increased airway secretions, a tracheos-
tomy was performed and feeding by nasogastric tube 
was established during his hospitalization. He was fi-
nally transferred to a long-term care sanatorium.
DISCUSSION
The patient initially did not have SIADH, but pre-
sented SIADH with pneumonia. He did not take any 
medicines known to cause SIADH. There is one report 
of L-dopa inhibiting ADH secretion10）. Our patient had 
taken levodopa/carbidopa before admission, and he re-
ceived levodopa intravenously during his hospitaliza-
tion. Therefore, it seems this drug would not have con-
tributed to his developing SIADH. Head computed 
tomography （CT） did not reveal any evidence of an 
intracranial space-occupying lesion. Body CT did not 
detect a malignancy. The only other cause of SIADH 
would be pneumonia.
and regular；and respiratory rate was 20 per minute. 
Body temperature was 38.0℃. SpO2 ranged from 95％ 
to 97％ under 5  /min oxygen. Tongue and oral muco-
sa were slightly dry. Coarse crackles were heard bilat-
erally in his anterior chest. There was no edema in his 
limbs. Chest X-ray revealed consolidations in both 
lungs. Arterial blood gas analysis revealed a pH of 
7 .454；PaO2 , 80 .9 mmHg；PaCO2 , 52 .3 mmHg；and 
HCO3
−, 35 .9 mEq/L under 5 L/min oxygen. A com-
plete blood count revealed elevated WBCs （predomi-
nantly neutrophils） and an elevated C-reactive protein 
level. Sputum and blood cultures revealed nonspecific 
findings. His urine was negative for the presence of 
antigens for Streptococcus pneumonia and legionella. 
Liver and renal functions were within normal limits. 
We diagnosed him as having aspiration pneumonia in-
duced by dysphagia.
Before admission, his serum sodium concentration 
ranged from 136 to 137 mEq/L. On admission, blood 
tests revealed he had hypotonic hyponatremia （his se-
rum sodium concentration was 132 mEq/L；serum os-
molality, 278 mOsm/L）；hypouricemia （serum uric 
acid concentration, 1 . 3 mg/dL）；hyperosmonuria 
（urine osmolality, 970 mOsm/L）；increased urinary 
sodium excretion （urine sodium concentration, 8 6 
mEq/L）；inappropriate secretion of ADH （plasma 
ADH concentration, 5.6 pg/mL）；and suppressed plas-
ma rennin activity （PRA, 0.2 ng/mL/hr）. Furthermore, 
his blood data did not indicate adrenal insufficiency 
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Fig. 1　The regulation of ADH secretion
Abbreviations：ADH, antidiuretic hormone；PVN, paraventricular nucleus；SON, supraoptic nucleus. 
SIADH with Shy-Drager syndrome
non-baroreceptor-mediated ADH release. CO2 reten-
tion may cause non-baroreceptor-mediated ADH re-
lease–there is one report of plasma ADH levels in-
creasing in hypercapnic edematous patients with 
COPD11）. There is an emerging awareness that inter-
leukin-6 has a role in the non-osmotic release of 
ADH12）. There is one report that plasma ADH re-
sponds to hypertonic saline infusion in people with 
SDS3）. Therefore, ADH secretion, despite low plasma 
osmolality, may result in a dysfunction of the osmore-
ceptors of the hypothalamus that respond to low plas-
ma osmolality9）. It is possible that a yet-to-be-deter-
Orthostatic hypotension in an upright position in 
people with SDS is thought to result from impaired 
baroreceptor-mediated ADH release1～4）. It is speculat-
ed that pneumonia-induced SIADH may be caused by 
another modulating baroreceptor5,6）. The modulating 
baroreceptor would reduce the inhibition of barorecep-
tor-mediated ADH release through the vagus and nu-
cleus tractus solitarius （Fig. 1）.
Why did pneumonia affect our patient’s barorecep-
tor-mediated ADH release （which had previously 
been impaired when in an upright position） ? One pos-
sibility is that pneumonia-induced SIADH is caused by 
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Table 1　Laboratory data on admission
White blood cell count 13000/mL CRP 4.5 mg/dL
Neutrophil 90％ Fastin plasma glucose 126 mg/dL
Lymphocyte 7.0％ Osmolality 278 mOsm/L
Monocyte 3.0％ ADH 5.6 pg/mL
Hemoglobin 11.3 g/dL Cortisol 15.6 mmg/dL
Hematocrit 38.0％ ACTH 48.2 pg/mL
Platelet 22.2×104/mL Plasma renin activity 0.2 ng/mL/hr
Total protein 5.9 g/dL Aldosterone 46 pg/mL
Albumin 2.46 g/dL Epinephrine ＜0.01 ng/mL
Na＋ 132 mEq/L Norepinephrine 0.02 ng/mL
K＋ 3.9 mEq/L Dopamine ＜0.02 ng/mL
Cl− 98 mEq/L FT4 1.03 ng/dL
Blood urea nitrogen 17 mg/dL FT3 1.83 pg/mL
Creatinine 0.6 mg/dL TSH 1.53 m IU/L
Uric acid 1.3 mg/dL Urine Na＋ 86 mEq/L
Aspartate aminotransferase 19 IU/L Urine K＋ 44.7 mEq/L
Alanine aminotransferase 9 IU/L Urine Cl− 154 mEq/l
Lactate dehydrogenase 297 IU/L Urine uric acid 54.4 mg/dL
Alkaline phosphatase 136 IU/L Urine creatinine 130.9 mg/dL
g-Glutamyltranspeptides 20 IU/L Urine osmolality 970 mOsm/L
Total bilirubin 0.5 mg/dL
Table 2　Laboratory data before and after SIADH treatment
on admission 3 weeks after admission
Serum Na （mEq/L） 132 135
Serum Osmolality （mOsm/L） 278 289
Serum Uric Acid （mg/dL） 1.3 1.5
Urine Na （mEq/L） 86 88
Urine Osmolality （mOsm/L） 970 528
Plasma ADH （pg/mL） 5.6 2.4
PRA （ng/mL/hr） 0.2 1.6
Abbreviations：ADH, antidiuretic hormone；PRA, plasma renin activity
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mined mechanism exists for non-baroreceptor-
mediated ADH release.
In summary, we report an extremely interesting 
case of Shy-Drager syndrome in which SIADH devel-
oped with pneumonia. The details of the pathophysio-
logical mechanism by which SIADH develops concomi-
tantly with pneumonia may be elucidated in the future.
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